A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.
Clinical trial NCT00903838 · TERMINATED
Trial details
- NCT number
- NCT00903838
- Sponsor
- Abbott Products
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-05-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.